NCT04231318Phase 3Completed

Study of Cingal® and Triamcinolone Hexacetonide for the Relief of Knee Osteoarthritis Pain

Study sponsor: Anika Therapeutics, Inc. · ANIK

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2022-05-16Actual
Enrollment · participants231Actual
Source updated2023-08-09Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview